JP2896235B2 - 局所フィブリノーゲン複合体 - Google Patents

局所フィブリノーゲン複合体

Info

Publication number
JP2896235B2
JP2896235B2 JP7524751A JP52475195A JP2896235B2 JP 2896235 B2 JP2896235 B2 JP 2896235B2 JP 7524751 A JP7524751 A JP 7524751A JP 52475195 A JP52475195 A JP 52475195A JP 2896235 B2 JP2896235 B2 JP 2896235B2
Authority
JP
Japan
Prior art keywords
composition
fibrinogen
thrombin
concentration
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP7524751A
Other languages
English (en)
Japanese (ja)
Other versions
JPH08512058A (ja
Inventor
ツェ，ダフネ，シー
マンカリウス，サミア，エス
リウ，シュ・レン
トーマス，ウィリアム，アール
アルパーン，メレーヌ
エノモト，スタンレー，ティー
ガランチョン，キャタリーヌ，エム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BAKUSUTAA INTERN Inc
Original Assignee
BAKUSUTAA INTERN Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22860054&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2896235(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by BAKUSUTAA INTERN Inc filed Critical BAKUSUTAA INTERN Inc
Publication of JPH08512058A publication Critical patent/JPH08512058A/ja
Application granted granted Critical
Publication of JP2896235B2 publication Critical patent/JP2896235B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP7524751A 1994-03-18 1995-03-17 局所フィブリノーゲン複合体 Expired - Lifetime JP2896235B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22915894A 1994-03-18 1994-03-18
US08/229,158 1994-03-18
US229,158 1994-03-18
PCT/US1995/003451 WO1995025748A1 (fr) 1994-03-18 1995-03-17 Complexe fibrinogene topique

Publications (2)

Publication Number Publication Date
JPH08512058A JPH08512058A (ja) 1996-12-17
JP2896235B2 true JP2896235B2 (ja) 1999-05-31

Family

ID=22860054

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7524751A Expired - Lifetime JP2896235B2 (ja) 1994-03-18 1995-03-17 局所フィブリノーゲン複合体

Country Status (5)

Country Link
EP (1) EP0699210A1 (fr)
JP (1) JP2896235B2 (fr)
AU (1) AU695266B2 (fr)
CA (1) CA2162997A1 (fr)
WO (1) WO1995025748A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1240200B1 (fr) * 1999-12-23 2009-06-03 Csl Limited Purification de fibrinogene present dans des proteases de plasma
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
AU2004208038B2 (en) 2003-01-30 2007-09-06 Prochon Biotech Ltd. Freeze-dried fibrin matrices and methods for preparation thereof
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
US7335508B2 (en) 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20090319045A1 (en) 2004-10-12 2009-12-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
EP1926459B1 (fr) 2005-09-19 2015-01-07 Histogenics Corporation Matrice support de cellules dont la densite des pores et la porosite sont definies specifiquement de maniere uniforme verticalement et organisees de maniere non aleatoire, et procede de preparation de celle-ci
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
WO2009109194A2 (fr) 2008-02-29 2009-09-11 Ferrosan A/S Dispositif pour la promotion de l’homéostasie et/ou la cicatrisation des plaies
EP2822474B1 (fr) 2012-03-06 2018-05-02 Ferrosan Medical Devices A/S Récipient mis sous pression contenant de la pâte hémostatique
EP2825216B1 (fr) 2012-06-12 2015-08-19 Ferrosan Medical Devices A/S Composition hémostatique sèche
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
JP6726852B2 (ja) 2014-10-13 2020-07-22 フェッローサン メディカル ディバイス エー／エス 止血および創傷治癒に使用するための乾燥組成物
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN107206165B (zh) 2014-12-24 2020-10-23 弗罗桑医疗设备公司 用于保持并混合第一和第二物质的注射器
JP6747651B2 (ja) 2015-07-03 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス 保管状態で真空を保持するための、及び２種の成分を混合するためのシリンジ
KR101841587B1 (ko) 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
KR20210008479A (ko) 2018-05-09 2021-01-22 훼로산 메디칼 디바이스 에이/에스 지혈 조성물을 제조하는 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229272T2 (de) * 1991-09-05 2000-02-03 Baxter International Inc., Deerfield Topischer fibrinogenkomplex

Also Published As

Publication number Publication date
AU1993795A (en) 1995-10-09
WO1995025748A1 (fr) 1995-09-28
AU695266B2 (en) 1998-08-13
EP0699210A1 (fr) 1996-03-06
CA2162997A1 (fr) 1995-09-28
JPH08512058A (ja) 1996-12-17

Similar Documents

Publication Publication Date Title
JP2896235B2 (ja) 局所フィブリノーゲン複合体
US5716645A (en) Topical fibrinogen complex
EP0602173B1 (fr) Composition a base de fibrinogene pour application topique
US5330974A (en) Therapeutic fibrinogen compositions
JP3825055B2 (ja) フィブリノーゲンを含む安定化された混合物
CA2201714C (fr) Procede pour l'extraction du facteur willebrand a haute purete
US5260420A (en) Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof
EP0654078B1 (fr) Fraction sanguine de thrombine destinee a etre utilisee en traitement medical
EP0082182B1 (fr) COMPOSITION A BASE DU FACTEUR HEMOSTATIQUE VIIa ET SON PROCEDE DE PREPARATION
US5099003A (en) Method of preparing a sterile plasma-protein solution containing fibrinogen and factor xiii
JP2004500026A (ja) 自己由来トロンビン
PT615454E (pt) Processo de preparacao de uma cola biologica enriquecida com factores plaquetarios e aplicacao
JPS5838216A (ja) 濃縮血漿誘導体製剤
WO1992013495A1 (fr) Adhesif a base de fibrinogene
JP2006516630A (ja) 抗凝固処理全血から産生される自己又は同種の凝固剤
US7211650B2 (en) Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography
KR20040058194A (ko) 보관이 안정한 피브리노겐 용액
JPH0530811B2 (fr)
JP2019196388A (ja) フィブリノゲン製剤
CA3009458A1 (fr) Procedes, compositions et kits pour reduire les adhesions tissulaires
CA2367124C (fr) Fraction thrombine du sang pour utilisation dans une procedure medicale
CN1073605A (zh) 通过采用低温沉淀物制备的改善的生物胶
MXPA99006754A (en) A stabilized mixture comprising fibrinogen